Taro Pharmaceutical Industries Ltd. Receives Nasdaq Notice Of Possible Delisting for Delayed Filing of 2005 Form 20-F

HAWTHORNE, N.Y.--(BUSINESS WIRE)--July 21, 2006--Taro Pharmaceutical Industries Ltd. ("Taro," the "Company," NASDAQ: TARO) reported today that on July 19, 2006 it received a Staff Determination from the Listing Qualifications Department of The Nasdaq Stock Market.
MORE ON THIS TOPIC